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Nanoparticulate architecture of protein-based 
artificial viruses is supported by  
protein–DNA interactions
Strategies for nonviral gene therapy are under 
continuous exploration, pressured by the unde-
sired side effects observed in viral-based gene 
therapy trials [1–5]. In this context, the ‘artificial 
virus’ approach implies the use of noninfectious 
and biologically safe entities that mimic relevant 
features of the viral life cycle, as DNA carriers for 
the cell-targeted delivery of therapeutic nucleic 
acids [6–8]. Liposomes, carbohydrates and pro-
teins are the most commonly used scaffolds for 
the construction of bio-inspired artificial viruses, 
although the functionalization necessary for spe-
cific receptor binding, endosomal escape and 
nuclear trafficking, among others, is mostly pro-
vided by proteins (namely peptides, full-length 
proteins or antibodies). In fact, proteins organ-
ized as cages in diverse forms, are considered 
excellent and fully biocompatible carriers for 
drug delivery [9]. In this regard, virus-like par-
ticles (VLPs) mainly formed by self-assembling 
capsid proteins from Papillomaviridae and 
Polyomaviridae viral families have been explored 
as gene therapy vehicles (once filled in vitro with 
nucleic acids) [10], either by keeping the original 
tropism of natural viruses or upon function-
alization by the appropriate display of foreign 
functional peptides. These studies have also been 
extended to bacterial viruses, which might be 
more convenient regarding scaled-up produc-
tion. For instance, phage MS2 VLPs loaded 
with antisense oligodeoxynucleotides and deco-
rated with transferrin have been proven active 
on leukemia cancer cells [11]. However, despite 
the convenient regularity of size exhibited by 
VLPs, their architectonic constraints limit 
their extensive engineering and the possibility 
of functional tuning.
A more versatile scheme of protein-based 
carriers for therapeutic nucleic acids are multi-
functional proteins, constructed by the combi-
nation of appropriate functional domains fused 
in a single polypeptide chain [12]. The integrated 
domains enable the whole construct to mimic 
the activities of the infective viral cycle that are 
relevant to the targeted delivery of nucleic acids 
(namely binding of DNA or RNA, cell attach-
ment and internalization, endosomal escape, 
proper cytoplasmic trafficking, eventual nuclear 
transport and nucleic acid release). The modular 
nature of such constructs permits the selection of 
functions using relevant peptides identified from 
nature or combinatorial libraries, and a func-
tional redesign in iterative improvement proc-
esses [13,14]. Diverse protein vehicles within this 
category have been successful in promoting sig-
nificant transgene expression levels in vitro [15–17] 
and therapeutic effects in vivo [18,19], proving the 
potential of this approach in the clinical context.
Interestingly, nonviral vehicles based on 
multi functional proteins have been scantily 
characterized from the morphologic point of 
view. Therefore, information regarding how 
these proteins might organize as building blocks 
of higher order structures, and how protein–
DNA complexes are formed and shaped is, in 
general, not available. Therefore, particle size 
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and molecular organization, nanoscale prop-
erties potentially critical for cell attachment, 
internalization and endosomal escape remain 
excluded from potential tailoring. To approach 
this issue, in Escherichia coli we produced two 
different versions of very short structural proteins 
as subunits for artificial viruses based on alterna-
tive combinations of four functional domains 
(an integrin-binding motif, an endosomal escape 
domain, a nuclear localization signal and a 
DNA-binding, cationic peptide) joined in short 
peptide stretches. Significant levels of transgene 
expression driven by the complexes have been 
observed, proving the appropriate selection of 
the functional domains. On the other hand, 
in the absence of DNA, protein blocks self-
organize as amorphous, polydisperse particulate 
entities ranging from a few nanometers up to 
approximately 1 µm. However, in presence of 
DNA, protein–DNA complexes appear as tight 
and rather monodisperse spherical-like nano-
particles of approximately 80 nm in diameter 
that resemble bacterial inclusion bodies (IBs), 
in which proteins remain attached by E-sheet-
based cross-molecular interactions. However, 
both protein modeling and structural ana lysis 
of these complexes reveal an unexpected molecu-
lar organization that does not rely on protein–
protein cross-molecular interactions but that is 
instead supported by protein–DNA interactions. 
Such DNA-mediated organization seems to gen-
erate an optimal architectural pattern of artificial 
viruses based on short multifunctional proteins 
as building blocks. 
Materials & methods
 Plasmid construction 
& protein sequence
Plasmid pET28aTEV, derived from pET28a 
(Invitrogen) in which the DNA sequence encod-
ing the thrombin cleavage site was substituted 
by a DNA fragment encoding a tobacco etch 
virus (TEV) protease cleavage site, was used to 
generate constructs pET28aTEV-HKRN and 
pET28aTEV-HNRK. HKRN and HNRK cor-
respond to DNA sequences coding for selected 
modules in the specif ied order (FIGURE 1A). 
Plasmids were constructed by introducing 
synthetic oligonucleotides, encoding the cor-
responding modules, into selected restriction 
enzyme sites of the multiple cloning site of 
pET28aTEV. The arginine–glycine–aspar-
tic motif used here derives from the foot-and-
mouth disease virus (serotype C1) cell-binding 
protein [20], and it is known to bind mammalian 
cells through DvE3 and D5E1 integrins [21,22]. The 
nuclear localization signal of the Simian virus 40 
(SV40) large T-antigen [23] has been universally 
used for the nuclear transport of delivered drugs 
and DNA [24]. The polylysine (Lys) tail (K10) 
is a cationic peptide extensively used as a DNA-
condensation agent in artificial viruses [25], while 
the polyhistidine tail (H6) is both an efficient 
endosomal-escape peptide [14] and a convenient 
tag for one-step protein purification from bac-
terial cell extracts [26]. Finally, the biologically 
irrelevant central amino acid stretch in both 
HKRN and HNRK was added to enlarge the 
mass of the resulting modular peptides and to 
make them more stable in bacterial cells, accord-
ing to our previous experience [Domingo-Espin J, 
Unpublished Data].
 Protein production & purification
The production of both chimerical proteins was 
triggered by the addition of 1 mM IPTG to plas-
mid-containing BL21(DE3) E. coli cell cultures 
(at OD = 0.4–0.6) growing in Luria–Bertani 
medium at 37°C. After 4 h, cells were harvested 
by centrifugation, washed with phosphate-buff-
ered saline and stored at -80°C until use. The pel-
let was resuspended in lysis buffer (20 mM Tris-
HCl pH 8, 500 mM NaCl and 6 M GuHCl) and 
cells were disrupted by sonication in the presence 
of EDTA-free protease inhibitor cocktail tablets. 
The soluble fraction was separated by centrifuga-
tion at 15,000 g for 45 min at 4°C and filtered 
through 0.22-µm filters. Proteins were purified in 
a single step by Ni2+ affinity chromatography in an 
ÄKTATM FPLC (GE Healthcare) using a 20 CV 
linear gradient to 100% of elution buffer (20 mM 
Tris-HCl pH 8.0, 500 mM NaCl, 6 M ClHGu 
and 1 M imidazole). Positive fractions were col-
lected and passed through a PD-10 desalting col-
umn (GE Healthcare) with 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid-buffered saline 
and quantified by Bradford’s method. Finally, 
proteins were stored at -80°C until use. IBs used 
for scanning electron microcopy were purified as 
described elsewhere [27].
 Mass spectrometry
Mass spectrometry was perfomed on 0.5 µl of 
protein sample mixed with 0.5 µl 2,4-dihydro-
xyacetophenone (10 mg/ml in 20 mM ammo-
nium citrate, 30% acetonitrile) spotted onto a 
ground steel plate (Bruker) and allowed to air-dry 
at room temperature. MALDI-mass spectra were 
recorded in the positive ion mode on an Ultraflex 
time-of-flight instrument (Bruker). Ion accelera-
tion was set to 20 kV. All mass spectra were exter-
nally calibrated using a standard protein mixture.
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Figure 1. HKRN and HNRK organization and main features. (A) Distribution of functional modules in HKRN, HNRK and the amino 
acid sequence of the whole protein constructs. In both cartoons and sequence, the histidine (H) tail is labeled in red, the lysine (K) tail in 
dark blue, the FMDV cell binding (arginine–glycine–aspartic [RGD]) in purple and the SV40 nuclear localization signal (NLS) in green. The 
irrelevant central region is depicted in gray. In the amino acid sequences, residues resulting from the cloning process are underlined, a 
tobacco etch virus protease target site introduced between H and the immediate carboxy module is indicated in boldface and the RGD 
motif within the FMDV peptide is shown in italics. Sizes of the modules in the cartoons are not intended to be representative of the 
actual length in the protein segments. (B) Cb staining and Wb ana lysis (using an anti-His antibody) of SDS-PAGE of HKRN and HNRK 
upon purification. Molecular masses of the markers (M) are indicated in the central column. (C) Mass spectrometry of both pure 
proteins. (D) Up-shift of pcDNA3.1 (harboring the tdTomato gene) mobility in agarose gel electrophoresis as induced by increasing 
amounts of HKRN and HNRK.  
†The protein–DNA charge and mass ratios at which migration of DNA is fully impeded (one retardation unit).
ReseaRch aRticle Domingo-Espín, Vazquez, Ganz et al.
future science group1050 Nanomedicine (2011) 6(6)
 Retardation assay
Different protein amounts were incubated 
with 300 ng of pcDNA3-tdTOMATO plas-
mid DNA resulting in 0.05, 0.1, 0.25, 0.5, 
0.75, 1, 1.5, 2.5, 5 and 7.5 protein/DNA w/w 
ratios, which corresponded to 0.05, 0.15, 
0.30, 0.40, 0.50, 0.80, 1.00, 1.40, 2.70 and 
4.10 protein/DNA charge ratios), respec-
tively. Mixtures were incubated in micro-
centrifuge tubes at room temperature for 1 h 
in 4-(2-hydroxyethyl)-1-piperazineethanesul-
fonic acid-buffered saline, and complex forma-
tion was detected in 0.8% agarose gels. One 
retardation unit (RU) is defined as the mini-
mum protein/DNA ratio that does not allow 
DNA migration on agarose gels.
 Electron microscopy
Complexes of protein and DNA were observed 
using transmission electron microscopy (TEM) 
with the aid of negative staining. One drop of 
the mixture was applied to glow-discharged 
carbon-coated copper grids (SPI Supplies®) for 
5 min and then drained off with filter paper. 
Subsequently, one drop of 2% uranyl acetate 
was placed on the grid for 2–3 min before 
being drained off. The grid was then placed in 
a transmission electron microscope (Jeol JEM 
1400) operating at an accelerating voltage of 
120 kV. Images were acquired using a CCD 
camera (Gatan) and saved as 8-bit images. A 
series of micrograph images were obtained tilt-
ing the sample from -60° to +60° with a 914 
High Tilt Holder.
Inclusion bodies were analyzed by scanning 
electron microscopy by standard procedures 
using Quanta FEI 200 f iled-emission gun 
environmental scanning electron microscope.
 Structural ana lysis
For circular dicroism (CD), samples were pre-
pared at a protein concentration of 200 µM. 
Two samples were incubated with DNA at dif-
ferent ratios corresponding to 0.5 and 2 RU. 
Cuvettes with path lengths of 0.1 cm were used, 
and eight scans recorded at 50 nm min (response 
of 2 s) in a JASCO 715 spectrophotopolarim-
eter were averaged for each variant. For Fourier-
transformed infrared spectroscopy (FTIR), 
samples were analyzed in a Bruker Tensor 27 
FTIR spectrometer (Broker Optics Inc.) For 
each spectrum, 16 scans were acquired at a spec-
tral resolution of 4 cm-1 in the 4000–600 cm-1 
range in the transmission mode. All process-
ing procedures were carried out to optimize the 
quality of the spectrum in the amide I region 
ranging from 1750 to 1550 cm-1. Second deriva-
tives of the amide I band spectra were used to 
determine the frequencies at which the different 
spectral components were located.
 Protein structure modeling
The 3D structures of the chimeric peptides were 
modeled with modeller 9v7 [28] using the coor-
dinates of the original protein segments (when 
available) as templates. Thus, the structures of 
the nuclear localization signal and arginine–gly-
cine–aspartic modules were based on chain  B 
of 1Q1S [29] and chain 5 of 1QGC [30], respec-
tively. The poly-Lys module was modeled, on the 
sole basis of the force field, as an unstructured 
segment, in line with the structural diversity 
reported for poly-Lys peptides [31] and the dis-
order of the poly-Lys tail in the structure with 
PDB code 1KVN [32]. The central region was 
modeled using chain A of 1HA0 [33] as a tem-
plate (61.9% similarity). Hexa-histidine peptides 
have become one of the most popular tags for 
protein purification, but the abundance of His-
tagged protein models contrast with the lack of 
structure in which this tag has been successfully 
solved. This fact clearly indicates that this region 
tends to be intrinsically unstructured and it was 
not suitable for modeling under our approach, 
being then absent in the models.
 Dynamic light scattering
Volume-size distribution of DNA–protein com-
plexes at different weight ratios was determined in 
a dynamic light scattering device (Zetasizer Nano 
ZS, Malvern Instruments Limited) using DTS 
(Nano) version 5.10 software for data evaluation.
 Transfection, flow cytometry 
analysis & fluorescent microscopy
The HeLa (ATCC-CCL-2) cell line was main-
tained in minimal essential medium (GIBCO) 
supplemented with 10% fetal calf serum 
(GIBCO) and incubated at 37°C and 5% 
CO2 in a humidified atmosphere in 24-well 
plates at a cell confluence of 70–80%. The vec-
tors pcDNA3-tdTOMATO and pEGFP-C1 
(Clontech), carrying the gene of the fluores-
cent proteins tdTOMATO and EGFP, respec-
tively, were used to monitor DNA transfection. 
DNA–HKRN or DNA–HNRK complexes were 
prepared incubating different amounts of pro-
tein in 50 µl OptiPRO (GIBCO)medium and 
different amounts of DNA in 50 µl OptiPRO 
(GIBCO) medium. After 5 min, DNA–protein 
complexes were generated by mixing DNA and 
protein at specified protein–DNA ratios at room 
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temperature for 1 h. A total of 100 µl OptiPRO 
(GIBCO) was then added to the mixture and then 
to the cells. Transfection and gene expression was 
monitored by flow cytometry in a FACSCalibur 
system (Becton Dickinson) at 24 h and confirmed 
at 48 h post-transfection in a fluorescence micro-
scope (Nikon ECLIPSE TE2000-E). As controls, 
we used nontreated cells, cells exposed only to the 
protein and cells exposed only to plasmid DNA.
 Primary cell cultures
Cortical neuron cultures were prepared from 
18-day-old Sprague–Dawley rat embryos 
(Charles River Laboratories), as described pre-
viously [34]. Animals were anaesthetized and 
killed by cervical dislocation. All procedures 
were approved by the Ethical Committee 
for Animal Use (CEEA) at the University of 
Barcelona, Spain. Cells were seeded on 24-well 
plates at a density of 1580 cells/mm2 in neuro-
basal medium supplemented with 2% B27 sup-
plement, 0.5 mM glutamine and 0.1 mg/ml 
gentamycin. Partial medium changes were per-
formed in vitro on days 4 and 7. Transfection 
was performed in vitro on day 10 as for HeLa 
cells, except that the transfection medium was 
neurobasal:conditioned medium (2:1). Gene 
expression was confirmed at 24 h postinfection 
in a fluorescence microscope (Olympus IX71).
 Luciferase gene expression
HKRN or HNRK were incubated at room 
temperature for 1 h with pGL3-BOS-luciferase 
reporter plasmid (kindly provided by Marta 
Barrachina) at the indicated ratios of protein/
DNA in 20–30 µl of Opti-MEM® medium. 
Subconfluent HEK293 cells were washed once 
with Opti-MEM and then incubated with the 
protein/DNA complexes for 4 h. The medium 
was then removed and cells maintained in 
DMEM+10% fetal bovine serum for another 
48 h. The measurement of luciferase activ-
ity was performed according to the manufac-
turer’s instructions (Luciferase Reporter Gene 
Detection Kit, SIGMA Cat. LUC1–1KT). As 
a control reference, cells were transfected with 
lipofectamine 2000 (Invitrogen, 2 µg lipo-
fectamine + 1 µg DNA/well on 24-well plate) 
and data were expressed as percentage relative 
light units per µg of protein in the samples 
compared with lipofectamine 2000.
Results
The chimerical genes encoding the multifunc-
tional proteins HKRN and HNRK were con-
structed by ligation of partially overlapping 
and complementary oligonucleotides, encod-
ing four selected protein domains, in which 
the codon usage had been optimized for E. coli. 
Both polypeptides, containing the same func-
tional motifs displayed in alternative positions 
(FIGURE 1A), were successfully produced in E. coli 
BL21 (DE3) pLysS, in full-length forms and at 
reasonably high yield (a4 µg of protein per ml of 
culture). Western blot analyses of purified pro-
teins revealed the absence of truncated protein 
versions and the minor occurrence of high molec-
ular mass immunoreactive species, especially in 
HKRN, which might indicate a tendency to 
form supramolecular structures (FIGURE 1B). The 
occurrence of such cross-interactions was sup-
ported by the high purity observed in samples of 
both proteins (FIGURE 1C), and the absence of major 
isoforms derived from partial proteo lysis. When 
HKRN and HNRK were challenged in DNA 
retardation assays, HKRN showed a higher capa-
bility (1 RU corresponding to a protein/DNA 
mass ratio of 1.5 and to a DNA/protein charge 
ratio of 0.8) than HNRK (1 RU correspond-
ing to a protein/DNA mass ratio of 2.5 and to a 
DNA/protein charge ratio of 1.3) to impede the 
mobility of plasmid DNA (FIGURE 1D). This diver-
gence could be accounted by either a different 
oligomerization potential or by a different per-
formance of the DNA binding domain (K10) as 
alternatively positioned in HKRN and HNRK. 
In the first case, K10 was placed in an internal 
position within the amino terminal protein moi-
ety and in HNRK, this peptide overhanged as a 
C-terminal end.
The resulting protein–DNA complexes (non-
viral vehicles) were tested in HeLa cell cultures 
for their ability to promote expression of a 
plasmid-harbored reporter transgene. Although 
the design of nonviral vehicles for gene therapy is 
a rather trial-and-error process, we expected that 
the combination of the FMDV integrin-binding 
motif, the SV40 nuclear localization signal, the 
His-based endosomal escape peptide and the Lys-
based DNA binding stretch could summarize the 
main viral functions required for cell uptake and 
trafficking of the cargo DNA and result in sig-
nificant levels of nuclear gene delivery and expres-
sion. In agreement with this presumption, flow 
cytometry ana lysis of cultured cells 48 h after 
exposure to HKRN–DNA and HNRK–DNA 
complexes revealed the occurrence of signifi-
cantly prevalent cell subpopulations expressing 
the reporter tdTomato gene. In this context, 
more than 10% of HeLa cells transfected with 
HNRK-based vehicles emitted red fluorescence, 
indicating the proper nuclear delivery and release 
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of the carried DNA. However, being still sig-
nificant, DNA delivery mediated by HKRN 
resulted in rather moderate transgene expres-
sion that was detected in only 0.5% of the cell 
population (FIGURE 2A). In order to eliminate the 
chance that this value could be due to experi-
mental noise, we examined the cultures treated 
with HKRN-based complexes by fluorescence 
microscopy in situ. Clear fluorescence emission 
in individual cultured HeLa cells was detected 
when using two different reporter genes, namely 
EGFP and tdTomato (involving >10% of cells at 
24 h; FIGURE 2B, top, middle panel). Furthermore, 
in primary cultures of neurons and glia, several 
cells strongly expressing tdTomato were observed 
24 h after transfection with the DNA–HKRN 
complex. A cell with neuronal morphology 
strongly expressing the tdTomato gene in the 
cell body and neurites is shown in the inset of 
FIGURE 2B, bottom, demonstrating that neurons can 
be effectively transfected and the transgene tran-
scribed and translated into protein. An additional 
transfection experiment on Hek293 cells with 
a third reporter luciferase (luc) gene confirmed 
the consistent transgene expression mediated by 
HKRN (FIGURE 2C). These data demonstrate the 
stability, robustness and good performance of 
both HKRN and HNRK as nonviral gene vec-
tors and the appropriateness of the selected pro-
tein modules to mediate DNA delivery, being the 
modular distribution in HNRK more convenient 
for the proper mimicking of viral functions.
Intriguingly, the morphology and structure 
of protein–DNA complexes in nonviral gene 
therapy has been historically neglected, and 
for protein-based vehicles other than VLPs, the 
concept of an artificial virus refers exclusively to 
functional (instead of nanoscale physical) prop-
erties. Therefore, at this stage, we were especially 
interested in evaluating the architectonic prop-
erties of both constructs as building blocks of 
artificial viruses, and how these multifunctional 
protein subunits should be organized to bind 
plasmid DNA. To explore the molecular organ-
ization of the artificial viruses we approached 
their structural ana lysis from different angles. 
Interestingly, the TEM images of both peptides 
alone indicated the occurrence of amorphous, 
highly dispersed protein clusters of approxi-
mately 1 µm without any apparent morphologi-
cal pattern and internal organization (FIGURE 3A). 
However, the protein–DNA complexes formed 
by HKRN and HNRK organized as regular, 
pseudo-spherical nanoparticles of approximately 
80 nm in diameter (FIGURES 3A), morphologically 
resembling bacterial IBs [35–37] (although these 
last particles can be slightly larger, up to 450 nm 
in diameter [35]). The molecular reorganization 
of the protein building blocks induced by the 
addition of DNA occurred at 0.5 but not 2 RU 
(FIGURE 3B), and it did not prevent the emergence 
of larger protein clusters (FIGURE 3B, see arrow). 
These micron-sized particles, as seen by dynamic 
light scattering, are probably transient and revers-
ible clusters of the 80-nm particles promoted by 
overhanging DNA molecules, since complexes of 
this size were uniquely, consistently and abun-
dantly observed by TEM (FIGURE 3A). Despite 
the absence of nanosized particles at 2 RU, the 
size variability of DNA–protein complexes was 
strongly reduced when comparing with proteins 
alone (FIGURE 3B), indicating that the presence of 
DNA promoted conformational alterations on 
the holding proteins with impact in their oli-
gomeric organization. The regularity of size in 
the protein–DNA complexes compared with the 
protein alone also indicates protein-condensing 
abilities of plasmid DNA that reduce the molec-
ular stickiness (their aggregation tendency) of 
HKRN and HNRK proteins. This fact strongly 
suggests that the cationic poly-Lys stretches, 
responsible for DNA binding in multifunc-
tional proteins [25] and whose charge is expected 
to be neutralized in the complexes, effectively 
drive the unspecific formation of higher order, 
protein-alone clusters shown in FIGURE 3A. Taken 
together, these data indicate that HKRN and 
HNRK, apart from exhibiting the functions 
associated to their forming protein domains, act 
as efficient building blocks for the construction 
of artificial viruses under the architectonic scope 
of this term.
A ±60° TEM scan of HNRK revealed a 
slightly flattened ellipsoid form of the protein–
DNA complexes (FIGURE 4A), again very similar to 
the images of IBs formed by other proteins seen 
by atomic force microscopy [35]. In fact, HKRN 
and HNRK themselves are both partially found 
as IBs in the cytoplasm of the producing bac-
teria (FIGURE 4C). In this context, we were inter-
ested in determining the eventual architectonic 
coincidences between protein–DNA complexes 
and IBs formed by the protein counterparts. As 
determined by conformational ana lysis through 
FTIR [38–40], IBs gain their mechanical struc-
ture and shape by cross-molecular protein–pro-
tein interactions supported by a E-sheet-based, 
amyloid-like architecture [41,42], and we won-
dered if the architecture of the 80-nm artificial 
viruses formed by HKRN–DNA and HNRK–
DNA complexes could also be supported by 
protein–protein interactions. 
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Therefore, we approached the FTIR ana lysis 
of artificial viruses and their protein building 
blocks taking HNRK as a model. HNRK con-
formational features were analyzed under differ-
ent biophysical states, such as naturally occurring 
IBs in bateria, in soluble form, lyophilized and 
in complexes with DNA. The conformational 
status of HNRK in IBs was found to be similar 
to those described previously as formed by other 
recombinant proteins, and characterized by the 
presence of extended, cross-molecular E-pleated 
sheet elements peaking at 1621 cm-1 (FIGURE 4B, 
top) [39,42,43]. On the other hand, in the HNRK–
DNA complexes other secondary elements not 
present in HNRK IBs, such as native D-helices 
and unordered structures, were also detected 
(corresponding to the overlapped region between 
1640 and 1660 cm-1). In agreement with that 
observed by in silico modeling (FIGURE 4D) and as 
expected for short peptides, both HKRN and 
HNRK are, in general, unstructured. However, 
some locally structured regions inherited from 
their templates were noted in the models, namely 
a three to ten helix spanning residues 44–47 
in HNRK and 45–48 in HKRN, apart from 
some additional turns and bends (FIGURE 4D). 
Accordingly, soluble HNRK was seen to have 
D-helix elements peaking at 1654 cm-1 (FIGURE 4B, 
center, green line). Interestingly, upon lyophiliz-
ing, HNRK seemed to evolve in a more lightly 
loose and unordered structure, as it can be seen 
by the broad peak between 1640 and 1660 cm-1 
(FIGURE 4B, center, black line). 
In agreement with the structural impact of 
DNA on the complexes suggested by dynamic 
light scattering data (FIGURE 3), the presence of the 
plasmid DNA had a critical effect on the pep-
tide structure (FIGURE 4B, bottom), preventing the 
smooth deconstruction of D-helices observed dur-
ing the lyophilization of HNRK alone. In addi-
tion, HNRK D-helices gained looseness along 
with the increase of DNA–HNRK ratio, as can 
be seen by the slight shift from lower wavenumber, 
from 1653 cm-1 in the lyophilized sample with-
out DNA (FIGURE 4B, bottom, black line) to 1651 
and 1650 cm-1 in the HNRK 2 RU and 0.5 RU 
(FIGURE 4 B, bottom, red line and blue line, respec-
tively). This minor but significant shift might 
suggest that the binding of DNA to the protein 
shells is not a random, but an organized event 
possibly involving the central D-helix region of 
the peptide. Such interaction could account for 
the architectonic organization emerging in the 
artificial viruses and absent in the protein build-
ing blocks alone. The gain of peptide organiza-
tion promoted by DNA was further confirmed 
G
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by CD ana lysis of HNRK alone and combined 
with DNA (FIGURE 4E), as evidenced by the reduc-
tion of the deep valley at 200 nm in the spectrum 
of the peptide in solution, which corresponds to 
disordered structure. In addition, the CD spectra 
of HNRK–DNA complexes at different ratios are 
compatible with the presence of secondary struc-
tures, such as D-helix or antiparallel E-sheet [44], 
which is particularly supported by the rising of 
peaks between 210 and 220 nm (FIGURE 4E). These 
results are in agreement with the FTIR spectra and 
with the compact nanoparticulated protein–DNA 
structures observed by TEM.
In summary, the FTIR ana lysis discarded any 
IB-like organization of artificial viruses and both 
FTIR and CD spectra demonstrated that the 
architecture of these particles is not based on 
cross-molecular protein–protein contacts but 
that it is instead supported by charge-dependent, 
but potentially stereospecific DNA–protein 
interactions. These contacts generate artificial 
viruses able to transfect expressible DNA, with 
morphologies and sizes within the nanoscale 
and compatible with those found optimal for 
efficient cell interaction and further uptake (in 
the range of those exhibited by natural virus par-
ticles) [45–47]. A further evidence of the architec-
tonic role of DNA in the organization of artifi-
cial viruses is that, upon treatment with DNAse, 
the HNRK-based artificial viruses disassemble 
in smaller entities whose lower range sizes (up 
to a10 and a40 nm), are compatible with those 
of peptide oligomers (FIGURE 3B).
Discussion
Artif icial viruses are manmade constructs 
designed to mimic viral activities important 
for the cell-targeted delivery of therapeutic 
nucleic acids [7], and represent safer alternatives 
to viral gene therapy [2,6]. Lipids and polysac-
charides with different molecular organizations 
are commonly used to protect nucleic acids that 
remain embedded in the core of the particle. 
However, because of the ability of proteins to 
interact with specific ligands, these vehicles are 
often functionalized with antibodies, peptides 
or whole proteins in an attempt to target a given 
cell type or tissue. Although tissue targeting in 
drug delivery can also be effectively achieved 
by distally applying magnetic force on para-
magnetic drug carriers [48], the versatility of 
protein engineering offers unique opportunities 
for the fine tailoring of the biological proper-
ties of artificial viruses to attain, for instance, 
complex biodistribution maps. 
In the context of the tunable nature of pro-
teins, artificial viruses can be efficiently con-
structed by uniquely using these macromolecules, 
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provided all the functions required by nucleic 
acid condensation and intracellular delivery are 
embraced. In this regard, an intriguing approach 
to protein-based artificial viruses is the design 
of multifunctional recombinant proteins [12], 
which contain, in a single polypeptide chain, 
functional peptides from different origins. By 
appropriate peptide selection and combination 
as functional modules, these units confer cellular 
specificity and intracellular traffic to the DNA–
protein complexes [13,14]. Those functional pep-
tides can either be inserted in permissive sites 
of a scaffold protein, or sequentially fused as a 
new, non-natural peptide or short protein [49] 
and produced in recombinant microorganisms. 
Examples of constructs generated in bacteria by 
these alternative strategies can be found else-
where [12]. Importantly, bacterially produced 
macro molecules are biocompatible, as proved 
by the high number of protein drugs approved 
for human therapy obtained in E. coli [50] (even 
being not a ‘generally recognized as safe’ [GRAS] 
organism), and also by the wide spectrum of 
bacterial materials used in classic and emerging 
medicines [51]. Therefore, the exploration of pro-
tein particles derived from bacterially produced 
components is perfectly reasonable regarding 
their potential clinical applicability.
From the material science point of view, the 
organization of protein-based cages has been clas-
sified according to rather general schemes [9,52], 
but the precise architecture of proteinaceous arti-
ficial viruses other than those based on VLPs 
remains poorly explored. In fact, multifunctional 
proteins based on large scaffold proteins such as 
E. coli E-galactosidase for instance [53,54], organ-
ize as amorphous polydisperse protein clusters 
whose properties seem to be defined by protein 
features (the enzyme is a tetramer of approxi-
mately 460 kDa [55]), rather than by the presence 
of DNA [56]. Upon addition, plasmid DNA does 
not modify the morphology of the complexes. In 
the same context, arginine-rich peptides, when 
displayed on the surface of a chimerical green 
f luorescent protein, provide self-assembling 
properties to the fusion protein (rendering pla-
nar 20-nm particles) also irrespectively of the 
presence of DNA [15]. 
Here we have explored the nanoscale organi-
zation of two short multifunctional proteins, 
namely HKRN and HNRK (FIGURE 1), which are 
shown to be competent in gene delivery by using 
both cultured cell lines and primary cell culture 
models (FIGURE 2A & 2B). The transgene expression 
levels and stability that were reached in this study 
were comparable or higher than those observed 
with previous prototypes of artificial viruses 
based on multifunctional proteins  [15,53,54,56,57], 
The less active modular protein version, namely 
the construct HKRN, achieved approximately 
18% of the expression level observed when using 
lipofectamine (FIGURE 2C). The slight differences 
in the ability to retain and deliver expressible 
DNA are obviously due to the alternative dispo-
sition of functional motifs, and the end terminal 
location of the cationic K10 peptide seems to 
be especially convenient for the performance of 
the whole vehicle. However, apart from such a 
punctual observation, no dramatic differences 
in the performance of HKRN and HNRK have 
been observed. This is indicative of an important 
extent of functional independence of the diverse 
modules composing the building block, which 
seems to be hardly affected by their particular 
position in the fusion peptide and also by the 
surrounding partner motifs. The mere sequen-
tial fusion of functional domains without any 
scaffolding protein seemed a favorable strategy 
regarding productivity in bacteria, when com-
paring with the moderate yield in which high 
molecular mass-engineered E-galactosidases had 
been obtained previously [53,56]. 
The building blocks alone tend to passively 
aggregate as amorphous clusters with average 
sizes of approximately 1 µm (FIGURE 3). However, 
the presence of DNA dramatically modifies 
the organization of the protein, and at 0.5 RU 
it induces the formation of protein–DNA 
nanoparticles of approximately 80 nm from 
which DNA molecules eventually overhang 
(FIGURES 3A & 4A). These artificial viruses, having 
optimal size regarding their potential interac-
tion with mammalian cells and further uptake 
[45], are able to promote the transgene expres-
sion in targeted cultured cells, as observed by 
several models (FIGURE 2), again more efficiently 
than amorphous vehicles based on larger scaffold 
proteins [53,56]. 
Interestingly, the organization of HKRN–DNA 
and HNRK–DNA complexes is not dependent 
on protein–protein interactions but on the sticky, 
glue-like potential of DNA (FIGURES 3B & 4B), that 
seems to show avidity for the internal D-helix 
exhibited by both proteins (FIGURE 4D). The archi-
tectonic properties of DNA in creating regular 
nanoparticles, based on charge-dependent inter-
actions [25], strongly depend on the protein–DNA 
ratio (FIGURE 3B) and are probably more apparent 
when interacting with short peptides than with 
large proteins, as no DNA-induced architectonic 
changes in larger protein building shells have 
been previously reported [15,56]. In this context, 
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the particle size (80 nm) observed here by using 
two short chimerical proteins has resulted very 
similar to that observed when associating other 
short peptides with plasmid DNA, namely in 
adenoviral core peptide µ–DNA complexes (80–
120 nm [58,59]) and in intermediates in toroid for-
mation by histidylated poly-Lys–DNA complexes 
(80–100 nm [60]). Poly-Lys–DNA and polyorni-
thine–DNA polyplexes have rendered, however, 
slightly larger particles (150–200 nm [61]). These 
organizing forces are probably dependent on the 
ability of DNA to alter the conformation of the 
shell proteins (FIGURE 4). In this context, it has been 
previously proved, by elegant ana lysis that short 
peptides affect the local, distal secondary and 
tertiary structure of bound DNA [62], but accord-
ing to the data presented here the conformational 
changes in protein–DNA artificial viruses are 
mutually induced.
In the context of multifunctional large proteins, 
we have previously shown that multi functional 
recombinant vehicles for DNA delivery efficiently 
induce the in vivo expression of a reporter [19] and 
a therapeutic gene [18], followed by reduced inf-
arct volume and functional recovery of treated 
animals [18], in a model of acute brain injury. 
Interestingly, the functional modules present in 
the protein shell can contribute, in synergy with 
the therapeutic gene, to the clinical recovery of 
the treated animals [57]. Being clearly efficient in 
local administration, further in vivo experiments 
are needed to evaluate the potential of the pro-
posed strategy for artificial virus construction in 
systemic gene therapy protocols, and how the pro-
tein–DNA complexes could be adapted to escape 
from the reticuloendothelial system.
Irrespective of that, the nanometric organ-
izing abilities of DNA-multifunctional protein 
complexes, reported for the first time in this 
study, opens intriguing possibilities for the 
design and development of improved artificial 
viruses. The small size of the protein counter-
part facilitates the DNA-mediated particle self 
organization, through interactions with the 
cationic protein motif. The functional plasticity 
of the multifunctional protein approach, com-
bined with the particle size adjustment should 
permit the generation of chemically hybrid and 
improved bionanoparticles for gene therapy but 
also conventional drug delivery. 
Conclusion
We have biologically produced short, mainly 
unordered multifunctional peptides as build-
ing blocks of protein-based artificial viruses, 
which have shown an excellent performance 
in transgene delivery under different biological 
models. Interestingly, the artificial viruses result-
ing from protein–DNA associations are pseudo-
spherical entities with regular particle sizes of 
approximately 80 nm, at specific protein–DNA 
ratios in the range of those promoting high trans-
gene expression levels. A structural characteriza-
tion of the protein components in these artificial 
viruses has revealed that the global architecture 
of the particles is not driven by protein–protein 
interactions but on the contrary, unexpectedly 
supported by the embedded DNA. The nucleic 
acids act as a compacting, molecular glue that 
affects the conformation of the protein build-
ing blocks, altering the D-helix structure of the 
central region, minimizing their aggregation ten-
dency and promoting an ordered, self organiza-
tion of the complexes in sizes compatible with an 
efficient receptor-mediated cell uptake and proper 
intracellular trafficking to the cell nucleus. This 
first description of the architectonic properties of 
DNA at the nanoscale opens intriguing oppor-
tunities for a better rational design of artificial 
viruses for gene therapy regarding their molecular 
and physical organization.
Future perspective
A better comprehension of the DNA–pro-
tein and protein–protein interactions in the 
context of nanoparticles for drug and DNA 
delivery (at this moment a rather neglected 
area) should offer new engineering tools for 
the semi-rational or rational tuning of the 
nanoscale properties of artif icial viruses, 
which is expected to fully expand in the next 
decade. The incorporation of protein-only 
vehicles (other than VLPs) in the nanomedi-
cal scenario will offer intriguing possibilities 
for the flexible development of smart drugs, 
especially when applying modular/multifunc-
tional protein engineering principles. However, 
the bio compatibility and safety of protein-
based nanoparticles should be combined with 
enhanced stability and improved targeting, the 
major challenges in the immediate generation 
of powerful drugs at the clinical level.
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Executive summary
  Short chimerical proteins produced in bacteria, that contain four functional domains relevant to intracellular trafficking, promote high 
transgene expression levels when used as artificial viruses. 
  The presence of DNA promotes conformational changes in the protein moiety of the artificial viruses that affects the minor D-helix 
region exhibited by rather unstructured peptides.
  The resulting artificial viruses are pseudo-spherical stable particles of approximately 80 nm, fully sustained by DNA–protein interactions 
rather than by protein–protein cross-molecular E-sheet interactions, which at difference from protein-only aggregates, are undetectable. 
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